1. A quantitative review and meta-models of the variability and factors affecting oral drug absorption-part II: gastrointestinal transit time;Abuhelwa;AAPS J.,2016
2. Revising the assessment of bioequivalence in the light of finite absorption time concept: The axitinib case. Poster submitted to 30th PAGE meeting;Alimpertis,2022
3. Center for Drug Evaluation and Research, 2002. Digoxin Bioequivalency Review 76268. https://www.accessdata.fda.gov/drugsatfda_docs/anda/2002/76268_Digoxin_Bioeqr.pdf.
4. BCS and BDDCS: beyond guidelines (Invited review);Charalabidis;Int. J. Pharm.,2019
5. Revising pharmacokinetics of oral drug absorption: II bioavailability-bioequivalence considerations;Chryssafidis;Pharm. Res.,2021